# Naproxen

## Naproxen 250mg

| TAH Drug Code      | [ONAP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONAP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ankylosing spondylitis, Bursitis, Gout acute, Osteoarthritis, Pain, Primary dysmenorrhea, Rheumatoid arthritis, Tendinitis acute.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Pain/Primary dysmenorrhea/Tendinitis, acute: Initial, 500 mg orally followed by 250 mg every 6 to 8 hours as required; titration, adjust dose and frequency to individual patient requirements; MAX 1250 mg/day. Ankylosing spondylitis/Osteoarthritis/Rheumatoid arthritis: Initial, 250 or 500 mg orally twice daily; morning and evening dose do not need to be the same size. Titration, may adjust up or down based on clinical response, lower daily doses may suffice for long-term use. If lower dosing is tolerated, a dose of 1500 mg/day may be used for up to 6 months if required. Gout, acute: Initial, 750 mg orally followed by 250 mg every 8 hours until attack has subsided.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | History of asthma, urticaria, or allergic-type reaction following aspirin or other NSAID administration. Use in the setting of CABG surgery                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common: Edema (3-9% .), Ecchymosis (3-9%), Pruritus (3-9%), Rash (3-9%), Abdominal pain (3-9%), Constipation (3-9%), Heartburn (3-9%), Nausea (3-9%), Dizziness (3-9%), Headache (3-9%), Somnolence (3-9%), Ototoxicity (3-9%), Tinnitus (3-9%), Dyspnea (3-9%). Serious: Body fluid retention, Congestive heart failure, Hypertension, Myocardial infarction, Vasculitis, Erythema multiforme, Erythroderma (<1%), Fixed drug eruption (<1%), Stevens-Johnson syndrome (<1%), Toxic epidermal necrolysis (<1%), Hyperkalemia, Gastrointestinal hemorrhage, Gastrointestinal perforation, Gastrointestinal ulcer, Hematemesis, Inflammatory bowel disease, Pancreatitis (<1%), Agranulocytosis (<1%), Anemia, Aplastic anemia, Granulocytopenic disorder, Hemolytic anemia, Hemorrhage, Thrombocytopenia (<1%), Thrombosis, Hepatitis, Hepatotoxicity, Increased liver function test, Jaundice (<1%), Liver failure, Anaphylaxis, Drug reaction with eosinophilia and systemic symptoms, Aseptic meningitis, Cerebrovascular accident, Seizure, Acute renal failure, Nephritis, Nephrotic syndrome, Nephrotoxicity, Renal failure, Bronchospasm, Pulmonary edema, Angioedema. |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/naproxen-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

